Cargando…
Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21(WAF1/CIP1) expression in ovarian cancer
BACKGROUND: Loss of growth inhibitory response to transforming growth factor-β (TGF-β) is a common feature of epithelial cancers. Recent studies have reported that genetic lesions and overexpression of oncoproteins in TGF-β/Smads signalling cascade contribute to the TGF-β resistance. Here, we showed...
Autores principales: | Chan, D W, Liu, V W S, To, R M Y, Chiu, P M, Lee, W Y W, Yao, K M, Cheung, A N Y, Ngan, H Y S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768441/ https://www.ncbi.nlm.nih.gov/pubmed/19755996 http://dx.doi.org/10.1038/sj.bjc.6605316 |
Ejemplares similares
-
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G(1)/S transition and apoptosis by targeting p21(WAF1/CIP1)
por: Wang, H, et al.
Publicado: (2014) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
The role of TGF-β1–miR-21–ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells
por: Jiang, Y, et al.
Publicado: (2014) -
Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.
por: Ogawa, M., et al.
Publicado: (1997) -
Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival
por: Ren, J, et al.
Publicado: (2011)